CVL-936

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameCVL-936
Drug Alias NameCVL-936
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonistsDopamine D3 receptor antagonists
TargetsDopamine D2 receptorDopamine D3 receptor
Therapy Area/IndicationsSubstance-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCerevel Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCerevel Therapeutics Llc
Active IndicationsN/A
Inactive IndicationsSubstance-Related Disorders

Other Information

ATC CodeN/A
Related LinksN/A